Clinical Presentation, Outcome and Risk Factors of Late-Onset Non- Infectious Pulmonary Complications After Allogeneic Stem Cell Transplantation

Publisher： Bentham Science Publishers

E-ISSN：  2212-3946|4|2|161-167

ISSN： 1574-888x

Source： Current Stem Cell Research & Therapy, Vol.4, Iss.2, 2009-05, pp. : 161-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Infectious complications following T-cell depleted hematopoietic stem-cell transplantation

By Novitzky N   Rouskova A  

Cytotherapy, Vol. 3, Iss. 3, 2001-05 ,pp. : 165-173

Ashgate Publishing Ltd

Access to resources Recommend Favorite

CD34 + -selected stem cell boost for delayed or insufficient engraftment after allogeneic stem cell transplantation

By Oyekunle Aa   Koehl U   Schieder H   Ayuk F   Renges H   Fehse N   Zabelina T   Fehse B   Klingebiel T   Sputtek A   Zander Ar   Kröger N  

Cytotherapy, Vol. 8, Iss. 4, 2006-08 ,pp. : 375-380

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Selective depletion strategies in allogeneic stem cell transplantation

By Mielke S   Solomon SR   Barrett AJ  

Cytotherapy, Vol. 7, Iss. 2, 2005-05 ,pp. : 109-115

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Adoptive transfer of Ag-specific T cells to prevent CMV disease after allogeneic stem-cell transplantation

By van Rhee F   Barrett J  

Cytotherapy, Vol. 4, Iss. 1, 2002-01 ,pp. : 3-10

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Mesenchymal Stem Cells for Treatment and Prevention of Graft-Versus- Host Disease After Allogeneic Hematopoietic Cell Transplantation

By  

Current Stem Cell Research & Therapy, Vol. 4, Iss. 4, 2009-12 ,pp. : 252-259

Bentham Science Publishers

Access to resources Recommend Favorite